Posts By: pharmanewsdaily

Uncategorized

Novartis’ Mayzent approved by FDA for treatment of relapsing forms of MS

Mayzent FDA approval : The US Food and Drug Administration (FDA) has approved Swiss pharma company Novartis’ Mayzent (siponimod) for

The post Novartis’ Mayzent approved by FDA for treatment of relapsing forms of MS appeared first on PharmaNewsDaily.com.

The post Novartis’ Mayzent approved by FDA for treatment of relapsing forms of MS appeared first on Business News Today.

Uncategorized

SOM Biotech raises €7m to support development of repurposing drugs for CNS

Spanish pharma company SOM Biotech, which is engaged in repurposing drugs for orphan diseases of the central nervous system (CNS),

The post SOM Biotech raises €7m to support development of repurposing drugs for CNS appeared first on PharmaNewsDaily.com.

The post SOM Biotech raises €7m to support development of repurposing drugs for CNS appeared first on Business News Today.

Uncategorized

Chinese pharma companies to evaluate combo therapy in colorectal cancer

Chinese pharma companies Innovent Biologics and Shenzhen Chipscreen Biosciences have agreed to evaluate their respective drugs as combination therapy in

The post Chinese pharma companies to evaluate combo therapy in colorectal cancer appeared first on PharmaNewsDaily.com.

The post Chinese pharma companies to evaluate combo therapy in colorectal cancer appeared first on Business News Today.

Scroll To Top